Prashant Bavi

20.9k total citations
76 papers, 2.8k citations indexed

About

Prashant Bavi is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Prashant Bavi has authored 76 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 28 papers in Oncology and 25 papers in Pathology and Forensic Medicine. Recurrent topics in Prashant Bavi's work include Lymphoma Diagnosis and Treatment (13 papers), Genetic factors in colorectal cancer (9 papers) and Colorectal Cancer Treatments and Studies (9 papers). Prashant Bavi is often cited by papers focused on Lymphoma Diagnosis and Treatment (13 papers), Genetic factors in colorectal cancer (9 papers) and Colorectal Cancer Treatments and Studies (9 papers). Prashant Bavi collaborates with scholars based in Saudi Arabia, United States and Canada. Prashant Bavi's co-authors include Shahab Uddin, Khawla S. Al‐Kuraya, Fouad Al‐Dayel, Maqbool Ahmed, Jehad Abubaker, Rong Bu, Abdul K. Siraj, Nasser Al‐Sanea, Zeenath Jehan and Azhar R. Hussain and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Prashant Bavi

75 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Prashant Bavi Saudi Arabia 34 1.4k 929 699 679 347 76 2.8k
Philip Jonsson United States 27 1.4k 1.0× 773 0.8× 902 1.3× 247 0.4× 485 1.4× 41 2.8k
Agnès Ribeiro France 27 1.3k 0.9× 704 0.8× 662 0.9× 239 0.4× 390 1.1× 49 2.7k
Héctor G. Pálmer Spain 25 1.7k 1.2× 891 1.0× 427 0.6× 1.2k 1.7× 620 1.8× 44 3.1k
Lisa Happerfield United Kingdom 27 995 0.7× 656 0.7× 658 0.9× 324 0.5× 199 0.6× 43 2.4k
Laura Rosanò Italy 35 2.1k 1.5× 915 1.0× 671 1.0× 226 0.3× 250 0.7× 63 3.7k
Valeriana Di Castro Italy 33 2.0k 1.4× 833 0.9× 641 0.9× 213 0.3× 257 0.7× 56 3.5k
Akiko Kokubu Japan 25 2.2k 1.5× 649 0.7× 594 0.8× 225 0.3× 122 0.4× 29 3.0k
Daniela Califano Italy 29 1.6k 1.1× 964 1.0× 577 0.8× 229 0.3× 137 0.4× 62 2.6k
Shuho Semba Japan 41 2.3k 1.6× 1.5k 1.7× 746 1.1× 659 1.0× 430 1.2× 85 4.0k
Bill Spohn United States 13 2.4k 1.7× 1.3k 1.4× 485 0.7× 237 0.3× 385 1.1× 20 3.2k

Countries citing papers authored by Prashant Bavi

Since Specialization
Citations

This map shows the geographic impact of Prashant Bavi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prashant Bavi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prashant Bavi more than expected).

Fields of papers citing papers by Prashant Bavi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prashant Bavi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prashant Bavi. The network helps show where Prashant Bavi may publish in the future.

Co-authorship network of co-authors of Prashant Bavi

This figure shows the co-authorship network connecting the top 25 collaborators of Prashant Bavi. A scholar is included among the top collaborators of Prashant Bavi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prashant Bavi. Prashant Bavi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mansoor, Adnan, et al.. (2023). Expression of “DNA damage response” pathway genes in diffuse large B‐cell lymphoma: The potential for exploiting synthetic lethality. Hematological Oncology. 42(1). e3225–e3225. 1 indexed citations
2.
Yang, Qian, Prashant Bavi, Julia Y. Wang, & Michael H. A. Roehrl. (2017). Immuno-proteomic discovery of tumor tissue autoantigens identifies olfactomedin 4, CD11b, and integrin alpha-2 as markers of colorectal cancer with liver metastases. Journal of Proteomics. 168. 53–65. 42 indexed citations
3.
Maurice, Catherine, Raphaël Schneider, Tim‐Rasmus Kiehl, et al.. (2015). Subacute CNS Demyelination after Treatment with Nivolumab for Melanoma. Cancer Immunology Research. 3(12). 1299–1302. 60 indexed citations
4.
Siraj, Abdul K., Sarita Prabhakaran, Prashant Bavi, et al.. (2015). Prevalence of Lynch syndrome in a Middle Eastern population with colorectal cancer. Cancer. 121(11). 1762–1771. 31 indexed citations
5.
Siraj, Abdul K., Rong Bu, Sarita Prabhakaran, et al.. (2014). A very low incidence of BRAF mutations in Middle Eastern colorectal carcinoma. Molecular Cancer. 13(1). 168–168. 35 indexed citations
6.
Bavi, Prashant, Zeenath Jehan, Rong Bu, et al.. (2013). ALK gene amplification is associated with poor prognosis in colorectal carcinoma. British Journal of Cancer. 109(10). 2735–2743. 34 indexed citations
7.
Siraj, Abdul K., Hanif Khalak, Mehar Sultana, et al.. (2012). Colorectal cancer risk is not associated with increased levels of homozygosity in Saudi Arabia. Genetics in Medicine. 14(8). 720–728. 13 indexed citations
8.
Siraj, Abdul K., Azhar R. Hussain, Maqbool Ahmed, et al.. (2011). Abstract 1492: FoxM1 expression and its association with matrix metalloproteinases in diffuse large B-cell lymphoma. Cancer Research. 71(8_Supplement). 1492–1492. 1 indexed citations
9.
Uddin, Shahab, Azhar R. Hussain, Maqbool Ahmed, et al.. (2010). Inhibition of Fatty Acid Synthase Suppresses c-Met Receptor Kinase and Induces Apoptosis in Diffuse Large B-Cell Lymphoma. Molecular Cancer Therapeutics. 9(5). 1244–1255. 40 indexed citations
10.
Hussain, Azhar R., Shahab Uddin, Maqbool Ahmed, et al.. (2010). Prognostic significance of XIAP expression in DLBCL and effect of its inhibition on AKT signalling. The Journal of Pathology. 222(2). 180–190. 51 indexed citations
11.
Abubaker, Jehad, Prashant Bavi, Zeenath Jehan, et al.. (2009). PIK3CA alterations in Middle Eastern ovarian cancers. Molecular Cancer. 8(1). 51–51. 34 indexed citations
12.
Uddin, Shahab, Prashant Bavi, Azhar R. Hussain, et al.. (2009). Leptin receptor expression in Middle Eastern colorectal cancer and its potential clinical implication. Carcinogenesis. 30(11). 1832–1840. 53 indexed citations
13.
Uddin, Shahab, Azhar R. Hussain, Prashant Bavi, & Khawla S. Al‐Kuraya. (2009). Inhibition of Fatty Acid Synthase Suppresses c-Met Receptor Kinase and Induces Apoptosis in Diffuse Large B Cell Lymphoma.. Blood. 114(22). 4787–4787. 1 indexed citations
14.
Jehan, Zeenath, Prashant Bavi, Mehar Sultana, et al.. (2009). Frequent PIK3CA gene amplification and its clinical significance in colorectal cancer. The Journal of Pathology. 219(3). 337–346. 48 indexed citations
15.
Uddin, Shahab, Maqbool Ahmed, Azhar Hussain, et al.. (2009). Bortezomib-mediated expression of p27Kip1 through S-phase kinase protein 2 degradation in epithelial ovarian cancer. Laboratory Investigation. 89(10). 1115–1127. 19 indexed citations
16.
Uddin, Shahab, Prashant Bavi, Abdul K. Siraj, et al.. (2009). Leptin-R and its association with PI3K/AKT signaling pathway in papillary thyroid carcinoma. Endocrine Related Cancer. 17(1). 191–202. 72 indexed citations
17.
Uddin, Shahab, Maqbool Ahmed, Prashant Bavi, et al.. (2008). Bortezomib (Velcade) Induces p27Kip1 Expression through S-Phase Kinase Protein 2 Degradation in Colorectal Cancer. Cancer Research. 68(9). 3379–3388. 66 indexed citations
18.
Uddin, Shahab, Maqbool Ahmed, Prashant Bavi, et al.. (2008). Bortezomib(Velcade) induces p27kip1 associated cell cycle arrest and apoptosis through down-regulation of SKP2 ubiquitin ligase pathway in colorectal carcinoma. Cancer Research. 68. 3265–3265. 1 indexed citations
19.
Abubaker, Jehad, Prashant Bavi, Sayer Al-harbi, et al.. (2007). Clinicopathological analysis of colorectal cancers withPIK3CA mutations in Middle Eastern population. Molecular Cancer Therapeutics. 6. 1 indexed citations
20.
Al‐Kuraya, Khawla S., Prashant Bavi, Adnan Ezzat, et al.. (2006). Colorectal carcinoma from Saudi Arabia. Analysis of MLH-1, MSH-2 and p53 genes by immunohistochemistry and tissue microarray analysis.. PubMed. 27(3). 323–8. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philip Jonsson Breakdown of academic impact, for papers by Agnès Ribeiro Breakdown of academic impact, for papers by Héctor G. Pálmer Breakdown of academic impact, for papers by Lisa Happerfield Breakdown of academic impact, for papers by Laura Rosanò Breakdown of academic impact, for papers by Valeriana Di Castro Breakdown of academic impact, for papers by Akiko Kokubu Breakdown of academic impact, for papers by Daniela Califano Breakdown of academic impact, for papers by Shuho Semba Breakdown of academic impact, for papers by Bill Spohn
Rankless by CCL
2026